• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Leading cancer researcher to receive honor from the Queen

Bioengineer by Bioengineer
January 3, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Professor Jack Cuzick from Queen Mary University of London (QMUL) will be appointed a Commander of the Order of the British Empire (CBE), as published today in the Queen's New Year 2017 Honours List.

The appointment, which has been recommended to the Queen by the Prime Minister, is in recognition of his achievements in cancer research, particularly the use of preventive medicine in cancer.

Professor Jack Cuzick, Director of QMUL's Wolfson Institute of Preventive Medicine and Head of the Centre for Cancer Prevention, said: "It is a great honour to be recommended for such a prestigious appointment. This is particularly important for the recognition it provides of the need to develop preventive therapies to tackle cancer before it occurs, much as now is done for heart disease.

"An enormous amount of research has been carried out which has provided clear evidence of the benefits of acting early to identify those at risk of cancer and prevent the onset of the disease with appropriate medication, rather than offering treatments when it may be too late."

The CBE comes just months after Professor Cuzick's election as a Fellow of the Royal Society.

Professor Cuzick was the first to show that the drug tamoxifen was highly effective in the prevention of breast cancer, and subsequently demonstrated the superior efficacy and safety of aromatase inhibitor drugs, which can reduce breast cancer incidence by over 50 per cent. He also developed a widely used model for assessing breast cancer risk.

The discovery that the human papilloma virus (HPV) was the cause of cervical cancer prompted Professor Cuzick to use HPV DNA testing as an alternative to the conventional Pap smear test. HPV testing has now become the primary screening method in many places. In collaboration with others, he also showed that a type of HPV vaccine can virtually eliminate cervical cancer, and will lead to a much reduced need for screening.

Professor Cuzick also developed a method to identify a larger group of prostate cancer patients that can be safely managed by active surveillance than was previously possible, thus avoiding the morbidity associated with surgery or radiation therapy.

###

For more information, please contact:

Joel Winston
Public Relations Manager (School of Medicine and Dentistry)
Queen Mary University of London
[email protected]
Tel: +44 (0)7970 096 188

Notes to the editor

Profiles of Professor Jack Cuzick can be found at:

  • http://www.wolfson.qmul.ac.uk/a-z-staff-profiles/jack-cuzick
  • http://www.cancerresearchuk.org/our-research/researchers/professor-jack-cuzick

About Queen Mary University of London

Queen Mary University of London (QMUL) is one of the UK's leading universities, and one of the largest institutions in the University of London, with 21,187 students from more than 155 countries.

A member of the Russell Group, we work across the humanities and social sciences, medicine and dentistry, and science and engineering, with inspirational teaching directly informed by our research. In the most recent national assessment of the quality of research, we were placed ninth in the UK (REF 2014).

As well as our main site at Mile End – which is home to one of the largest self-contained residential campuses in London – we have campuses at Whitechapel, Charterhouse Square, and West Smithfield dedicated to the study of medicine, and a base for legal studies at Lincoln's Inn Fields.

We have a rich history in London with roots in Europe's first public hospital, St Barts; England's first medical school, The London; one of the first colleges to provide higher education to women, Westfield College; and the Victorian philanthropic project, the People's Palace at Mile End.

Today, as well as retaining these close connections to our local community, we are known for our international collaborations in both teaching and research.

QMUL has an annual turnover of £350m, a research income worth £125m (2014/15), and generates employment and output worth £700m to the UK economy each year.

Media Contact

Joel Winston
[email protected]
44-079-700-96188
@QMUL

http://www.qmul.ac.uk

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Efficient Lithium/Sodium Iron Silicate Cathodes via Milling

Efficient Lithium/Sodium Iron Silicate Cathodes via Milling

September 23, 2025
Metal-Doped Prussian Blue Nanoparticles Enhance Battery Anodes

Metal-Doped Prussian Blue Nanoparticles Enhance Battery Anodes

September 23, 2025

How Federal Health Surveys Are Measuring Sexual Orientation, Gender Identity, and Differences in Sex Development

September 22, 2025

Gene Analysis Uncovers Metal Exposure in Synechococcus

September 22, 2025
Please login to join discussion

POPULAR NEWS

  • Physicists Develop Visible Time Crystal for the First Time

    Physicists Develop Visible Time Crystal for the First Time

    69 shares
    Share 28 Tweet 17
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Efficient Lithium/Sodium Iron Silicate Cathodes via Milling

Metal-Doped Prussian Blue Nanoparticles Enhance Battery Anodes

How Federal Health Surveys Are Measuring Sexual Orientation, Gender Identity, and Differences in Sex Development

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.